Constipation Pipeline Review, H1 2019 Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Constipation
– Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Constipation – Pipeline Review, H1 2019, provides comprehensive
information on the therapeutics under development for Constipation
(Gastrointestinal), complete with analysis by stage of development, drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type. The guide covers the descriptive pharmacological action
of the therapeutics, its complete research and development history and
latest news and press releases.

The Constipation (Gastrointestinal) pipeline guide also reviews of key
players involved in therapeutic development for Constipation and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies/Universities/Institutes, the
molecules developed by Companies in Pre-Registration, Phase III, Phase
II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 8, 2,
4, 1 and 1 respectively. Similarly, the Universities portfolio in
Discovery stages comprises 1 molecule, respectively.

Constipation (Gastrointestinal) pipeline guide helps in identifying and
tracking emerging players in the market and their portfolios, enhances
decision making capabilities and helps to create effective counter
strategies to gain competitive advantage.

Scope

• The pipeline guide provides a snapshot of the global therapeutic
  landscape of Constipation (Gastrointestinal).
• The pipeline guide reviews pipeline therapeutics for Constipation
  (Gastrointestinal) by companies and universities/research institutes
  based on information derived from company and industry-specific
  sources.
• The pipeline guide covers pipeline products based on several stages of
  development ranging from pre-registration till discovery and
  undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline
  products which comprise, product description, descriptive licensing
  and collaboration details, R&D brief, MoA & other developmental
  activities.
• The pipeline guide reviews key companies involved in Constipation
  (Gastrointestinal) therapeutics and enlists all their major and minor
  projects.
• The pipeline guide evaluates Constipation (Gastrointestinal)
  therapeutics based on mechanism of action (MoA), drug target, route of
  administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued
  pipeline projects.
• The pipeline guide reviews latest news related to pipeline
  therapeutics for Constipation (Gastrointestinal).

Companies Mentioned

• Allergan Plc
• Ardelyx Inc
• Braintree Laboratories Inc
• Dong-A ST Co Ltd
• Ironwood Pharmaceuticals Inc
• Kissei Pharmaceutical Co Ltd
• MallInckrodt Plc
• NGM Biopharmaceuticals Inc
• RaQualia Pharma Inc
• Sanwa Kagaku Kenkyusho Co Ltd
• Sumitomo Dainippon Pharma Co Ltd
• Synergy Pharmaceuticals Inc
• Synthetic Biologics Inc
• Vanda Pharmaceuticals Inc
• Yuhan Corp
• Zensun (Shanghai) Sci & Tech Co Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/a2l3iv

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Gastrointestinal
Drugs